A Silicon Valley-based healthcare technology company developing a handheld robotic interventional platform, Mendaera has closed US$73 million in Series B funding.
The funding round was led by Threshold Ventures, with support from other investors including Lux Capital, PFM Health Sciences, and Fred Moll who is the founder of Intuitive Surgical, and Auris Health.
The financing will support Mendaera’s efforts to scale robotics and artificial intelligence across mainstream medical procedures.
READ MORE: Flow Robotics and Global Focus announce US distribution partnership
Traditionally, robots in healthcare have thus far been primarily been limited to high-end, singularly focused surgeries, and the company is aiming to make their use more common across every part of medical care.
The company’s handheld interventional platform includes robotics, AI, real-time imaging, and virtual connectivity.
It is designed to be accessible across specialties and sites of service to empower providers and systems, to better meet the growing demand for needle-based interventions.
Josh DeFonzo, Founder and CEO of Mendaera, said: “Traditional surgical robots have established footing in the operating room.
“But robotics and AI have evolved to a point where we can deliver broader benefits across all parts of the healthcare system and enable higher standards of care for more patients.
“We believe that our technology will allow healthcare systems and providers to provision medical procedures at scale – enhancing patient experience, increasing access to high-quality care, reducing overall cost, and improving healthcare provider satisfaction.”
Innovations and achievements in robotics in healthcare will be highlighted and celebrated at the second annual Robotics & Automation Awards on 06 November 2024 at De Vere Grand Connaught Rooms in London. Visit www.roboticsandautomationawards.co.uk to learn more about this unmissable industry event – and to book your table!
